Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique

American Journal of Pathology

Volumn 150, Issue 5, 1997, Pages 1571-1582

  Greene, Graham F ^a   Kitadai, Yasuhiko ^a   Pettaway, Curtis A ^a   Von Eschenbach, Andrew C ^a   Bucana, Corazon D ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGENASE; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; CANCER TRANSPLANTATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CARCINOMA; RNA TRANSCRIPTION;

ANIMALS; BLOTTING, NORTHERN; CARCINOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; RNA, MESSENGER; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030969422     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Fidler U: Critical factors in the biology of human cancer metastasis: Twenty-Eighth GHA Clowes Memorial Award Lecture. Cancer Res 1990, 50:6130-6138
2. Wingo PA, Tong T, Bolden S: Cancer statistics, 1995, CA Cancer J Clin 1995, 45:8-30
3. Grignon DJ, Hammond EH: College of American Pathologists Conference XXVI on Clinical Relevance of Prognostic Markers in Solid Tumors: Report of the Prostate Cancer Working Group. Arch Pathol Lab Med 1995, 119:1122-1126
4. Partin AW, Yoo J, Ballentine CH, Pearson JD, Chan DW, Epstein JI, Walsh PC: The use of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993, 150:110-114
5. Sgrignoli AR, Walsh PC, Steinberg GD, Steiner MS, Epstein JI: Prognostic factors in men with stage D1 prostate cancer: identification of patients less likely to have prolonged survival after radical prostatectomy. J Urol 1994, 152:1077-1081
6. Zincke H, Oesterling JE, Blute ML, Bergstralh EJ, Myers RP, Barrett DM: Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 1994, 152:1850-1857
7. Poste G, Fidler U: The pathogenesis of cancer metastasis. Nature 1979, 283:139-146
8. Turkeri LN, Sakr WA, Wykes SM, Grignon DJ, Pontes JE, Macoska JA: Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant, and malignant prostate tissue. Prostate 1994, 25:199-205
9. Radinsky R, Risin S, Fan D, Dong Z, Bielenberg D, Bucana CD, Fidler IJ: Level of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1995, 1:19-31
10. Mydlo JH, Michaeli J, Heston WDW, Fair WR: Expression of basic fibroblast growth factor mRNA in benign prostatic hyperplasia and prostatic carcinoma. Prostate 1988, 13:297-304
11. Singh RK, Bucana CD, Gutman M, Fan D, Wilson MR, Fidler IJ: Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. Am J Pathol 1994, 145:365-374
12. Singh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ: Expression of interleukin-8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 1994, 54:3242-3247
13. Ishiko T, Sakamoto K, Yamashita SI, Masuda Y, Kamohara H, Mita S, Hirashima M, Ogawa M: Carcinoma cells express IL-8 and the IL-8 receptor; their inhibition attenuates the growth of carcinoma cells. Int J Oncol 1995, 6:119-122
14. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980, 284:67-68
15. Stearns M, Stearns ME: Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression. Oncol Res 1996, 8:69-75
16. Boag AH, Young ID: Increased expression of the 72-kd type IV collagenase in prostatic adenocarcinoma. Am J Pathol 1994, 144:585-591
17. Weinstein RS, Jakate SM, Dominguez JM, Lebovitz MD, Koukoulis GK, Kuszak JR, Klusens LF, Grogan TM, Saclarides TJ, Roninson IB, Coon JS: Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis, Cancer Res 1991, 51:2720-2726
18. Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HFM, Oosterhof GON, Debruyne FMJ, Schalken JA: Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 1994, 54:3929-3933
19. Cheng L, Nagabhushan M, Pretlow TP, Amini SB, Pretlow TG: Expression of E-cadherin in primary and metastatic prostate cancer. Am J Pathol 1996, 148:1375-1380
20. Fidler U, Radinsky R: Genetic control of cancer metastasis. J Natl Cancer Inst 1990, 50:6130-6138
21. Wright JA, Egan SE, Greenberg AH: Genetic regulation of metastatic progression. Anticancer Res 1990, 10: 1247-1256
22. Hart IR, Easty D: Identification of genes controlling metastatic behavior. Br J Cancer 1991, 63:9-12
23. Liotta LA, Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991, 51:5054-5059
24. Radinsky R, Bucana CD, Ellis LM, Sanchez R, Cleary KR, Brigati DJ, Fidler IJ: A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. Cancer Res 1993, 53:937-943
25. Bucana CD, Radinsky R, Dong Z, Sanchez R, Brigati DJ, Fidler IJ: A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdr-1 in mouse colon carcinoma cells. J Histochem Cytochem 1993, 41:499-506
26. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW: Establishment and characterization of a human prostate carcinoma cell line (PC-3). Invest Urol 1979, 17:16-23
27. Koslowski JM, Fidler IJ, Campbell D, Xu Z, Kaighn ME, Hart IR: Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 1984, 44:3522-3529
28. Pettaway CA, Pathak S, Greene GF, Ramirez E, Wilson M, Killion JJ, Fidler IJ: Selection of highly metastatic variants of human prostatic carcinoma utilizing orthotopic implantation in nude mice. Clin Cancer Res 1996, 2:1627-1636
29. Stephenson RA, Dinney CPN, Gohji K, Ordonez NG, Killion JJ, Fidler IJ: Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst 1992, 84:951-957
30. Pettaway CA, Stephenson RA, Fidler IJ: Development of orthotopic models of metastatic human prostate cancer, Cancer Bull 1993, 45:424-429
31. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH: Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 1984, 309:418-428
32. Rogelj S, Weinberg RA, Fanning P, Klagsbrun M: Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature 1988, 331:173-175
33. Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W, Appella E, Kung HF, Leonard EJ, Oppenheim JJ: Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin-1 and tumor necrosis factor. J Exp Med 1988, 167:1883-1893
34. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Selzter JL, Kronberger A, He C, Bauer EA, Goldberg GI: H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J Biol Chem 1988, 263:6579-6587
35. Bussenmakers MJG, van Bokhoven A, Mees SGM, Kemler R, Schalken JA: Molecular cloning and characterization of the human E-cadherin cDNA. Mol Biol Rep 1993, 17:123-128
36. Galski H, Sullivan M, Willigham MC, Chin KV, Gottesman MM, Pastan I, Merlino GT: Expression of a human multidrug resistance cDNA (mdr-1) in the bone marrow of transgenic mice: resistance to daunomycin-induced leukopenia. Mol Cell Biol 1989, 9:4357-4363
37. Pearson WR, Lipman DJ: Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 1988, 85:2444-2448
38. Caruthers MH, Beaucage SL, Efcavitch JW, Fisher EF, Goldman RA, DeHaseth PL, Mandecki W, Matteucci MD, Rosendahl MS, Stabinsky Y: Chemical synthesis and biological studies on mutated gene-control regions. Cold Spring Harbor Symp Quant Biol 1982, 47: 411-418
39. Kitadai Y, Bucana CD, Ellis LM, Anzai H, Tahara E, Fidler IJ: In situ mRNA hybridization technique for analysis of metastasis-related genes in human colon carcinoma cells. Am J Pathol 1995, 147:1238-1247
40. Kitadai Y, Ellis LM, Takahashi Y, Bucana CD, Anzai H, Tahara E, Fidler U: Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas. Clin Cancer Res 1995, 1:1095-1102
41. Parks CS, Brigati DJ, Manahan LJ: Automated molecular pathology: one hour in situ DNA hybridization. J Histotechnol 1991, 14:219-229
42. Reed JA, Manahan LJ, Park CS, Brigati DJ: Complete one-hour immunocytochemistry based on capillary action. Biotechniques 1992, 13:434-443
43. Radinsky R, Kraemer PM, Raines MA, Kung HJ, Culp LA: Amplification and rearrangement of Kirsten ras oncogene in virus-transformed BALB/3T3 cells during malignant tumor progression. Proc Natl Acad Sci USA 1987, 84:5143-5147
44. Fort P, Marty L, Liechaczyk M, Sabrouty SE, Dani C, Blanchard JM: Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate dehydrogenase multigene family. Nucleic Acids Res 1985, 13:1431-1442
45. Nagafuchi A, Shirayoshi Y, Okazaki K, Yasuda K, Takeichi M: Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA. Nature 1987, 329:341-343
46. Feinberg AP, Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983, 132:6-13
47. Zar JM: Biostatistical Analysis, ed 2. Englewood Cliffs, NJ, Prentice Hall, 1984, pp 162-186
48. Kitadai Y, Ellis LM, Tucker SL, Greene GF, Bucana CD, Cleary KR, Takahashi Y, Tahara E, Fidler U: Multipara-metric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma. Am J Pathol 1996, 149:1541-1551
49. Morris GL, Dodd JG: Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J Urol 1990, 143:1272-1274
50. Montone KT, Tomaszewski JE: In situ hybridization for epidermal growth factor receptor (EGFR) external domain transcripts in prostatic adenocarcinoma. J Clin Lab Anal 1993, 7:188-195
51. Nakamoto T, Chang C, Li A, Chodak GW: Basic fibroblast growth factor in human prostate cancer cells. Cancer Res 1992, 52:571-577
52. Stearns ME, Wang M: Regulation of kinesin expression and type IV collagenase secretion in invasive human prostate PC-3 tumor sublines. Cancer Res 1991, 51: 5866-5875
53. r 72,000) expression in human prostate benign and malignant tissue. Cancer Res 1993, 53:878-883
54. Theyer G, Schirmbock M, Thalhammer T, Sherwood ER, Baumgartner G, Hamilton G: Role of the mdr-1-encoded multidrug resistance phenotype in prostate cancer cell lines. J Urol 1993, 150:1544-1547
55. Rokhlin OW, Cohen MB: Expression of cellular adhesion molecules on human prostate tumor cell lines, Prostate 1995, 26:205-212
56. Giroldi LA, Schalken JA: Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications, Cancer Metastasis Rev 1993, 12:29-37
57. Anzai H, Kitadai Y, Bucana CD, Sanchez R, Omoto R, Fidler U: Intratumoral heterogeneity and inverse correlation between expression of E-cadherin and collagenase type IV in human gastric carcinomas. Differentiation 1996, 60:119-127